Convection-enhanced delivery for the treatment of pediatric neurologic disorders

Journal of Child Neurology

Volumn 23, Issue 10, 2008, Pages 1231-1237

  Song, Debbie K ^a,b   Lonser, Russell R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Blood brain barrier; Central nervous system; Convection enhanced delivery; Drug delivery

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE; GLUCOSYLCERAMIDASE; INTERLEUKIN 13; PARVOVIRUS VECTOR; PSEUDOMONAS EXOTOXIN;

ABDUCENS NERVE PARALYSIS; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DISTRIBUTION VOLUME; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SAFETY; GAUCHER DISEASE; GLIOMA; HUMAN; LETHARGY; MOLECULAR WEIGHT; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN STEM NEOPLASMS; CATHETERS, INDWELLING; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CONVECTION; GLIOMA; HUMANS; INFUSION PUMPS, IMPLANTABLE;

EID: 53549083211     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808321064     Document Type: Conference Paper

References (23)

1. Pardridge WM Drug delivery to the brain. J Cereb Blood Flow Metab. 1997; 17: 713-731.
2. Morrison P. Distribution models of drug kinetics. In: Atkinson AJ Jr, Daniels CE, Dedrick RL, et al, eds. Principles of Clinical Pharmacology. New York: Academic Press; 2001: 93-112.
3. Bobo RH, Laske DW, Akbasak A., et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA. 1994; 91: 2076-2080.
4. Bruce JN, Falavigna A., Johnson JP, et al. Intracerebral clysis in a rat glioma model. Neurosurgery. 2000; 46: 683-691.
5. Kunwar S., Prados MD, Chang SM, et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol. 2007; 25: 837-844.
6. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 2003; 9: 589-595.
7. Lonser RR, Walbridge S., Garmestani K., et al. Successful and safe perfusion of the primate brainstem: In vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg. 2002; 97: 905-913.
8. Lonser RR, Weil RJ, Morrison PF, et al. Direct convective delivery of macromolecules to peripheral nerves. J Neurosurg. 1998; 89: 610-615.
9. Lonser RR, Gogate N., Morrison PF, et al. Direct convective delivery of macromolecules to the spinal cord. J Neurosurg. 1998; 89: 616-622.
10. Chen MY, Lonser RR, Morrison PF, et al. Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg. 1999; 90: 315-320.
11. Szerlip NJ, Walbridge S., Yang L., et al. Realtime imaging of convection-enhanced delivery of viruses and virus-sized particles. J Neurosurg. 2007; 107: 560-567.
12. Lonser RR, Warren KE, Butman JA, et al. Realtime image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg. 2007; 107: 190-197.
13. Degen JW, Walbridge S., Vortmeyer AO, et al. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg. 2003; 99: 893-898.
14. Voges J., Reszka R., Gossmann A., et al. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol. 2003; 54: 479-487.
15. Sampson JH, Akabani G., Friedman AH, et al. Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. Neurosurg Focus. 2006; 20: E14.
16. Croteau D., Walbridge S., Morrison PF, et al. Realtime in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg. 2005; 102: 90-97.
17. Laske DW, Morrison PF, Lieberman DM, et al. Chronic interstitial infusion of protein to primate brain: Determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg. 1997; 87: 586-594.
18. Nguyen TT, Pannu YS, Sung C., et al. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg. 2003; 98: 584-590.
19. Lonser RR, Schiffman R., Robison RA, et al. Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology. 2007; 68: 254-261.
20. Sampson JH, Brady ML, Petry NA, et al. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: Descriptive effects of target anatomy and catheter positioning. Neurosurgery. 2007; 60 (2 suppl 1): ONS89-98; discussion ONS98-89.
21. Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics. 2008; 5: 123-127.
22. Hargrave D., Bartels U., Bouffe E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 2006; 7: 241-248.
23. Mignot C., Doummar D., Maire I., et al. Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev. 2006; 28: 39-48.